Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

EnviroLogix™ Signs Collaborative Agreement with Douglas Scientific™

Published: Tuesday, July 24, 2012
Last Updated: Tuesday, July 24, 2012
Bookmark and Share
The agreement will see the companies develop and optimize solutions for high throughput real time and endpoint nucleic acid analysis.

The companies will leverage and build upon EnviroLogix’ revolutionary isothermal DNAble®v2.0 chemistry and Douglas Scientific’s disruptive Array Tape™ Platform.

The DNAble isothermal amplification and detection technology represents a new paradigm in real time nucleic acid analysis and has the potential to impact the world of molecular biology. This new DNAble assay solution developed by EnviroLogix delivers results equivalent to qPCR in less than 10 minutes with the demonstrated ability to utilize crude sample preparations. These attributes make this solution equally valuable for point-of-use testing as well as extremely high throughput applications.

“The substantial improvement in throughput with DNAble alone is significant, but when combined with the Douglas Scientific Array Tape solutions it becomes revolutionary,” said Dan Malmstrom, President and COO of Douglas Scientific. “By partnering with EnviroLogix, we can provide end-to-end qualitative and quantitative nucleic acid testing automation solutions that break the current paradigms of qPCR.”

DNAble is a very rapid, highly specific isothermal nucleic acid amplification technology that can amplify both RNA and DNA targets with single base resolution a billion-fold in 5-10 minutes at a single and constant temperature.  It features EnviroLogix’ next generation DNAble, v2.0 chemistry.  The proprietary chemistry produces highly specific, rapid, multiplexed, quantitative results rivaling qPCR.  Unlike PCR, DNAble can amplify a target sequence from a crude sample preparation and do so with minimal equipment. DNAble’s unique amplification process begins with a nicking enzyme that nicks the DNA structure at specific recognition sites.  A polymerase then extends from the “nicked” site displacing the original opened single strand.  These single strands hybridize with both the forward and reverse DNAble templates and the reaction begins to occur at an exponential rate yielding a detectable target in less than 10 minutes.

“We are delighted to be associated with a fast-paced, growing organization like Douglas Scientific, and believe that this will be a winning combination of chemistry and engineering” said Bruce Ferguson, President and CEO of EnviroLogix. “PCR was once a fledgling technology and now is the gold standard. That is how we view DNAble. Combined with the power of Douglas Scientific’s automated high throughput equipment, DNAble brings a game-changing technological breakthrough in real time quantitative molecular diagnostics.”

Array Tape™ is a continuous polymer strip, serially embossed with reaction wells in customized volumes and formats. With miniaturized reaction wells, this thin (0.3 mm) and flexible solution allows 200 microplate equivalents (76,800 reaction wells) to be spooled onto a single, compact reel. It is an automated, adaptable microplate replacement for high throughput screening.

Douglas Scientific provides inline, modular instrumentation that is fully integrated and optimized for use with Array Tape™ including Nexar® liquid handling and assay processing system, Soellex® thermal cycler, Araya® fluorescent detection instrumentation and software solutions. The platform enables a continuous reel-to-reel process flow to maximize throughput and reduce costs.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Douglas Scientific, LGC Distribution Agreement
Companies have formalized an exclusive distribution agreement for the sale of Douglas Scientific’s innovative Array Tape® Platform.
Monday, August 11, 2014
Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos